Other ingredients
Microcrystalline Cellulose; Hypromellose; Water; Stearic Acid (C18:0); Silica; Magnesium Stearate (Mg Stearate); Medium Chain Triglyceride Oil (MCT)
Image: NIH Office of Dietary Supplements, Dietary Supplement Label Database — No separate image reuse license stated
XYMOGEN
Nattokinase
Capsule
Serving size1 Capsule(s)
Servings per containerNot listed
Package120 Vegetarian Capsule(s)
Data retrievedJul 28, 2026
Supplement Facts
Serving size 1 Capsule(s)
Nattokinase100 mgDV not established
Label directions
Directions: Take one to two capsules twice daily at least 30 minutes before or two hours after a meal; or as directed by your healthcare professional.
Label warnings
Consult your healthcare professional prior to use. Individuals taking medication should discuss potential interactions with their healthcare professional. Do not use if tamper seal is damaged. Cautions: Consult your healthcare professional before taking this product if you have a bleeding disorder or are taking any drug that affects blood coagulation or blood pressure such as heparin warfarin (Coumadin) diuretics ACE inhibitors or beta blockers. Storage: Keep closed in a cool dry place out of reach of children.
Identity and label version
NIH label record335506
Entered into NIH DSLDJul 24, 2025
UPC / GTIN00871149002480
Manufacturer / distributor on labelXYMOGEN Exclusive Professional Formulas
Market statusOn market in the source data
“Entered into NIH DSLD” is the database entry date for this label record. It is not a manufacturer launch date or a label effective date.
NIH label history (3)
Current labelNIH record 335506Entered Jul 24, 2025
Nattokinase100 mg
Label warning: Consult your healthcare professional prior to use. Individuals taking medication should discuss potential interactions with their healthcare professional. Do not use if tamper seal is damaged. Cautions: Consult your healthcare professional before taking this product if you have a bleeding disorder or are taking any drug that affects blood coagulation or blood pressure such as heparin warfarin (Coumadin) diuretics ACE inhibitors or beta blockers. Storage: Keep closed in a cool dry place out of reach of children.
Earlier labelNIH record 303769Entered Dec 14, 2023
Nattokinase100 mg
Label warning: Consult your healthcare practitioner prior to use. Individuals taking medication should discuss potential interactions with their healthcare practitioner. Do not use if tamper seal is damaged. Cautions: Consult your health care practitioner before taking this product if you have a bleeding disorder or are taking any drug that affects blood coagulation or blood pressure such as heparin warfarin (Coumadin) diuretics ACE inhibitors or beta blockers. Storage: Keep closed in a cool dry place out of reach of children.
Earlier labelNIH record 66421Entered Nov 21, 2016
Nattokinase100 mg
Label warning: Individuals taking medication should discuss potential interactions with their healthcare practitioner. Do not use if tamper seal is damaged. Cautions: Consult your health care practitioner before taking this product if you have a bleeding disorder or are taking any drug that affects blood coagulation or blood pressure such as heparin warfarin (Coumadin) diuretics ACE inhibitors or beta blocks. Storage: Keep closed in a cool dry place out of reach of children. Contains: Soy. Consult your healthcare practitioner prior to use. Cautions: Consult your health care practitioner before taking this product if you have a bleeding disorder or are taking any drug that affects blood coagulation or blood pressure such as heparin warfarin (Coumadin) diuretics ACE inhibitors or beta blocks.
Sources and traceability
- NIH Dietary Supplement Label DatabaseData retrieved Jul 28, 2026Open source ↗
More from XYMOGEN
Data comes from product labels or official public sources. It does not mean Safmira, NIH, or FDA approves, certifies, or recommends this product. Label amounts are not laboratory measurements.